Bio-pharmaceutical company to explore collaboration opportunities during largest U.S. government-led trade and business development event Rockville, MD – March 7, 2023 – Tasly Pharmaceuticals, Inc., “dedicated to a healthier world,” will participate in the Trade Winds ASEAN Mission and Business Forum March 13-15 in Bangkok, Thailand. The Trade Winds event, organized by the U.S. Commercial […]
Bio-pharmaceutical company to join with Maryland-based organizations at Asia’s premier biotechnology partnering event Rockville, MD – October 5, 2022 – Tasly Pharmaceuticals, Inc., “dedicated to a healthier world,” will join a delegation of other Maryland-based bio-pharmaceutical companies at BioJapan 2022, Asia’s premier partnering event for the global biotechnology sector, in Yokohama, Japan, October 12 to […]
We invite you to consider collaborating with Tasly Pharmaceuticals Inc. if you are interested in shaping the future of medicine and enhancing the quality of life for individuals in the United States and globally. Our primary focus is on botanical medicine’s ultimate potential, and we aim to integrate practices refined over thousands of years into […]
Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc, is nearing the end of what has been a long road of testing to get approval from the US Food and Drug Administration (FDA) for its T89 drug (Dantonic), multiple components innovative Chinese Medicine (ICM). Dantonic, the drug has been shown to have few adverse […]
ROCKVILLE, MD – Tasly Pharmaceuticals Co. Ltd. of China and Tasly Pharmaceuticals, Inc. of USA, a global leader in pharmaceuticals, biologics and nutraceuticals, announced that its three-herb composition drug T89 (Dantonic), has been shown in a Phase 3 global clinical trial to improve Treadmill exercise duration (TED) and more effectively reduce the frequency of chronic […]